Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News GlaxoSmithKline sees the future in imaging

GlaxoSmithKline sees the future in imaging

1st November 2005

GlaxoSmithKline is investing in the skills and experience of three scientists from the academic sphere to boost it clinical imaging programme.

Reuters reports that the company hopes developing imaging technology will help the company realise a better understanding of how drugs interact inside the body and in such a way speed up pharmaceuticals development.

GlaxoSmithKline has appointed Paul Matthews, from the University of Oxford to head up a centre for magnetic resonance imaging, positron emission tomography and optical imaging based at the Hammersmith Hospital campus of Imperial College London.

The company has invested ??46 million in to the centre and Imperial College and the Medical Research Council are also providing ??20 million and ??9 million respectively.

The other appointments are Ed Bullmore, of Cambridge University, who has been appointed vice president of experimental medicine and Marc Laruelle, from Columbia University College of Physicians and Surgeons, who has been appointed vice president for clinical molecular imaging.

track© Adfero Ltd

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.